Video | October 15, 2026

Moving Faster, With Confidence: An Interview With Ulrike Bauer, Chief Business Officer At Ypsomed

Source: Ypsomed

Pressure to shorten development timelines keeps rising, yet speed alone can simply move risk and bottlenecks further downstream.

In this interview, Ulrike Bauer, Chief Business Officer at Ypsomed, makes the case that acceleration depends on pairing platform flexibility with readiness: the data, documentation, manufacturing and supply needed to keep a program moving without avoidable iteration. She considers how that balance differs for clinical-stage programs, including earlier device introduction in Phase 2, and for generic and biosimilar pathways. She also looks past approval to the constraints that can surface at commercial scale, from local manufacturing in China and the US to the interfaces between device, container, fill-finish and assembly.

Watch the interview to hear her perspective on keeping drug delivery off the critical path.

Access The Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Delivery Leader